Beyond a consensus classification for idiopathic interstitial pneumonias: progress and controversies by Myers, Jeffrey L. & Katzenstein, Anna-Luise A.
REVIEW
Beyond a consensus classification for idiopathic interstitial
pneumonias: progress and controversies
Jeffrey L Myers & Anna-Luise A Katzenstein1
Departments of Pathology at University of Michigan School of Medicine, Ann Arbor, MI, and 1SUNY Upstate Medical
University, Syracuse, NY, USA
Myers J L & Katzenstein A-L A
(2009) Histopathology 54, 90–103
Beyond a consensus classification for idiopathic interstitial pneumonias: progress and
controversies
Histopathological classification schemes provide the
underpinnings for separating idiopathic interstitial
pneumonias into clinically meaningful groups. An
interdisciplinary classification system based on a com-
bination of evidence and expert opinion was published
in 2002 and set the stage for controversy in several
areas, including not only nomenclature but also the
role of surgical lung biopsy and pathologists in diag-
nosis. We provide a brief overview of the clinical and
histological features of the idiopathic interstitial pneu-
monias, and focus on selected topics of interest that
have emerged in recent years.
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Introduction
Idiopathic interstitial pneumonias are an important
subset of the broader category of diffuse, non-neoplastic
interstitial lung diseases.1 The common feature is
unexplained expansion and distortion of distal lung
interstitium by variable combinations of inflammation
and ⁄ or fibrosis. Fibrosis, when present, may take the
form of increased numbers of fibroblasts and myofibro-
blasts and ⁄ or collagen deposition. These changes occur
in the context of breathlessness or cough, typically
associated with evidence of physiological dysfunction
and diffuse radiological abnormalities.
Averill Liebow pioneered the notion that morpho-
logical classification of idiopathic interstitial pneumo-
nias is useful in separating them into distinct clinical
categories.2 Since then a number of classification
schemes have been proposed. In 2002 an inter-
national committee, supported by the American
Thoracic Society (ATS) and the European Respiratory
Society, proposed a classification scheme based on
consensus opinion developed by a large interdisciplin-
ary group of experts.3 This statement has had a
profound impact, influencing management of patients
with suspected idiopathic interstitial pneumonias, driv-
ing study design for clinical trials and creating oppor-
tunities for research to challenge areas in which
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evidence was weak. The purpose of this review is to
summarize briefly current knowledge of the clinical and
histological features of the idiopathic interstitial pneu-
monias, focusing primarily on areas of controversy that
have emerged in recent years.
Classification of idiopathic interstitial
pneumonias
The consensus classification proposed seven categories
of idiopathic interstitial pneumonia, ordering them by
relative frequency and separating ‘histological pat-
terns’ from ‘clinical-radiological-pathological diagno-
sis’ (see Table 1).3 We prefer a simplified approach
that uses a single unifying terminology and omits
cryptogenic organizing pneumonia, also termed idio-
pathic bronchiolitis obliterans organizing pneumonia
(BOOP) and lymphoid interstitial pneumonia (LIP).4
The rationale for omitting idiopathic BOOP from this
schema is that this disease pathologically is predom-
inantly an air space, rather than interstitial process,
and clinically it usually mimics infectious pneumonias
rather than a diffuse interstitial process. LIP is omitted
because it represents a form of lymphoproliferative
disorder more closely allied to follicular bronchiolitis
on one hand and low-grade lymphoma on the other,
and thus it differs from the inflammatory interstitial
pneumonias. The simplified approach will serve as the
framework for this review. We will return to the
values and risks of separating histological patterns
from clinical diagnoses toward the end of our
discussion.
Usual interstitial pneumonia
Usual interstitial pneumonia (UIP) is the most common
of the idiopathic interstitial pneumonias, accounting
for about 60% of biopsied patients.5–7 An ATS con-
sensus statement published in 2000 linked UIP to
idiopathic pulmonary fibrosis (IPF) by defining the
latter as ‘a specific form of chronic fibrosing interstitial
pneumonia limited to the lung and associated with
histological appearance of usual interstitial pneumonia
(UIP) on surgical (thoracoscopic or open) lung biopsy’.8
As this definition implies, UIP and IPF are interchange-
able terms, the potential exceptions being those
patients with underlying systemic illnesses or occupa-
tional exposures that may suggest an aetiology for their
lung disease (e.g. asbestosis).
clinical features
Patients with UIP usually present in the sixth or
seventh decade of life with slowly progressive dyspnoea
and non-productive cough. Men are affected more
commonly than women by a ratio of nearly 2:1.
Physical findings include bibasilar inspiratory crackles,
a non-specific but characteristic finding in nearly all
patients. Pulmonary function studies show restrictive
abnormalities (i.e. reduced lung volumes with relative
preservation of airflow) in most patients accompanied
by a reduction in the diffusion capacity for carbon
monoxide (DLCO) with hypoxaemia at rest and ⁄ or with
exercise. No single pharmacological agent or combina-
tion of drugs has shown consistent efficacy in patients
Table 1. Classification of idiopathic interstitial pneumonias
Katzenstein
International consensus classification
Histological patterns Clinical-radiological-pathological diagnoses
Usual interstitial pneumonia (UIP) Usual interstitial pneumonia (UIP) Idiopathic pulmonary fibrosis (IPF)
Desquamative interstitial pneumonia
(DIP) ⁄ respiratory bronchiolitis
interstitial lung disease (RBILD)
Desquamative interstitial pneumonia
(DIP)
Desquamative interstitial pneumonia (DIP)
Respiratory bronchiolitis Respiratory bronchiolitis interstitial lung
disease (RBILD)





Non-specific interstitial pneumonia (NSIP)
Organizing pneumonia Cryptogenic organizing pneumonia (COP)
Lymphoid interstitial pneumonia
(LIP)
Lymphoid interstitial pneumonia (LIP)
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with UIP, although a large number of novel therapies
are being investigated in clinical trials. Lung trans-
plantation is used in some patients, but its application
is limited due to older age and frequent comorbidities.
In most patients UIP pursues a progressive course, with
median survivals from the time of diagnosis of about
3 years.5,9
Occasional patients present with a more acute onset
of respiratory symptoms that may mimic the clinical
presentation of acute interstitial pneumonia (AIP).10,11
This syndrome has been termed acute exacerbation of
IPF (or accelerated UIP) and occurs in as many as 14%
of untreated patients observed for 2 years.12 A recent
autopsy study suggests that acute exacerbation is a
common cause of death in UIP patients.13 Acute
exacerbation is defined as the sudden onset of rapid
clinical deterioration without an identifiable cause in
patients with IPF. A diagnosis of acute exacerbation
hinges on exclusion of other known and potentially
treatable causes of clinical worsening, such as cardiac
disease, pulmonary embolism, and infection. Most
patients are known to have UIP at the time of acute
worsening, but a few patients present with acute
exacerbation without a previously established diagno-
sis of IPF. The prognosis is grim, with short-term
mortality rates in excess of 50% in the majority of
reported series.
The relative role of imaging studies and surgical
lung biopsies in patients with UIP has changed over
the last decade. High-resolution computed tomogra-
phy (HRCT) has greatly improved diagnostic accuracy
over conventional chest radiography and has there-
fore revolutionized the role of radiology in managing
patients with diffuse interstitial lung diseases. HRCT in
about half of patients shows a characteristic combi-
nation of peripheral (subpleural), irregular, linear
(‘reticular’) opacities involving predominantly the
lower lung zones with associated architectural dis-
tortion in the form of traction bronchiectasis and
bibasilar honeycomb change.14–17 Experienced radiol-
ogists can make a specific diagnosis of UIP with a high
degree of accuracy in patients with this combination
of findings, thus obviating the need for lung biopsy.
Lung biopsy is increasingly limited to those patients
with atypical radiological findings, meaning that there
is a growing selection bias toward reserving surgical
lung biopsy for patients with potentially ‘discordant’
or atypical radiological findings. It is this change that
has created confusion around the relative roles of
clinicians, radiologists and pathologists in biopsied
patients. In this context, the bulk of the evidence
indicates that a biopsy diagnosis of UIP remains the
single most important predictor of outcome at the
time of diagnosis and thus remains the ‘gold standard’
for diagnosis.14,18
pathologic features
UIP is a specific morphological entity defined by a
combination of (i) fibrosis distributed in a hetero-
geneous (‘patchwork’) fashion, (ii) fibroblast foci, and
(iii) honeycomb change and ⁄ or scars.1,4,19 The histo-
logical hallmark and chief diagnostic criterion in
surgical lung biopsy specimens is a heterogeneous or
variegated appearance resulting from irregular juxta-
position of fibrotic scarring, honeycomb change, inter-
stitial inflammation and normal lung (Figure 1). This
distinctive ‘patchwork’ appearance due to alternating
areas of qualitatively different abnormalities is the key
to low-magnification diagnosis.
Fibrosis predominates over inflammation in classical
UIP and comprises mainly dense eosinophilic collagen
deposition. Fibroblast foci are a characteristic but non-
specific finding, representing small interstitial foci of
acute lung injury in which fibroblasts and myofibro-
blasts are arranged in a linear fashion within a pale
staining matrix (Figure 2). Overlying epithelium con-
sists of hyperplastic pneumocytes or columnar non-
ciliated bronchiolar cells. Fibroblast foci are not unique
to UIP, but are a very important feature in establishing
the diagnosis. The presence of these microscopic zones
of acute lung injury set against a backdrop of chronic
scarring further contributes to the variegated appear-
ance (temporal heterogeneity) typical of UIP.
Figure 1. Low-magnification photomicrograph of usual interstitial
pneumonia demonstrating characteristic ‘patchwork’ distribution
of fibrosis (H&E). Areas of collagen fibrosis are distributed in a random
fashion with only minimal inflammation. Scattered fibroblast foci
are also present (arrows).
92 J L Myers & A-L A Katzenstein
 2008 The Authors. Journal compilation  2008 Blackwell Publishing Ltd, Histopathology, 54, 90–103.
Honeycomb change is present in most surgical lung
biopsy specimens and is another important diagnostic
feature. Honeycomb change is defined by cystically
dilated air spaces frequently lined by columnar respi-
ratory epithelium in scarred, fibrotic lung tissue
(Figure 3). Fibrotic scars that obscure the underlying
lung architecture without associated honeycomb
change are another form of architectural distortion
characteristic of UIP. Smooth muscle hyperplasia is
commonly seen in areas of fibrosis and honeycomb
change and can be striking in some cases.
Biopsy specimens from patients with acute exacer-
bation usually show a combination of UIP and
superimposed diffuse alveolar damage (DAD) or, less
often, organizing pneumonia (Figure 4).10,11 The
features of DAD may be patchy and typically include
some combination of confluent alveolar septal thick-
ening and distortion by fibroblasts and myofibroblasts
with minimal associated inflammatory cells, marked
hyperplasia and cytological atypia in type 2 pneumo-
cytes, hyaline membranes, fibrin thrombi in small
vessels, and squamous metaplasia of bronchiolar
epithelium. In other patients the superimposed pattern
of acute lung injury more closely resembles organizing
pneumonia.
Figure 2. High-magnification photomicrograph showing a fibroblast
focus in usual interstitial pneumonia (H&E). Fibroblasts and myo-
fibroblasts are confined to a small interstitial area and are arranged
in a somewhat linear fashion within a pale-staining matrix. Hyper-
plastic epithelial cells are present overlying the fibroblast focus.
A
B
Figure 4. Surgical lung biopsy specimen showing a combination of
usual interstitial pneumonia and diffuse alveolar damage in a patient
with acute exacerbation of idiopathic pulmonary fibrosis. A, Low-
magnification photomicrograph showing underlying fibrosis includ-
ing a broad zone of scarring and honeycomb change in lower right
portion (H&E). B, Higher-magnification photomicrograph from area
in upper left of previous image showing expansion and distortion
of interstitium by fibroblasts and myofibroblasts with associated
hyaline membrane (arrows) (H&E).
Figure 3. Low-magnification photomicrograph showing honeycomb
change in usual interstitial pneumonia (H&E). Cystically dilated air
spaces are lined by bronchiolar-type epithelium and are situated
within scarred, fibrotic lung.
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No single histological finding consistently predicts
prognosis in individual patients with UIP. Patients with
more extensive fibroblast foci have experienced shorter
mean survivals in some studies, whereas other inves-
tigators have failed to demonstrate the same relation-
ship to survival.20
Desquamative interstitial pneumonia ⁄
respiratory bronchiolitis interstitial
lung disease
Desquamative interstitial pneumonia (DIP) and respi-
ratory bronchiolitis interstitial lung disease (RBILD) are
two highly related, if not inseparable, forms of diffuse
interstitial lung disease typically grouped with the
idiopathic interstitial pneumonias. We have collapsed
the two into a single category for reasons described
later. DIP ⁄ RBILD is uncommon, accounting for only a
small minority of surgical lung biopsy specimens from
patients with idiopathic interstitial pneumonias.5
clinical features
DIP ⁄ RBILD affects younger patients, with a mean age
at diagnosis in the fourth or fifth decade of life.1,4
Nearly all patients have strong histories of cigarette
smoking, prompting many to consider DIP ⁄ RBILD a
form of smoking-related interstitial lung disease.23,47
Physiological testing usually shows mild reduction in
lung volumes associated with a moderate decrease in
diffusing capacity. Radiological abnormalities are com-
mon but relatively non-specific. HRCT shows patchy
ground glass opacities, often with a lower lung zone
distribution, without the traction bronchiectasis and
honeycomb change typical of UIP.
DIP ⁄ RBILD is associated with a significantly better
prognosis than UIP. Overall survival in published studies
of DIP is nearly 90%, ranging from around 70–80% in
older studies to 100% in more recently published
series.1,21 Higher survival rates in more recent studies
may reflect a trend toward assigning cases with associ-
ated fibrosis to the category of non-specific interstitial
pneumonia (NSIP) (see Controversies below). RBILD is
associated with an equally good or better prognosis.21–23
Retrospective case series suggest smoking cessation as
an important therapeutic strategy, but the impact on
outcome is controversial.22
pathological features
DIP ⁄ RBILD is characterized by the presence of pig-
mented (‘smokers’) macrophages within the lumens of
distal airways (i.e. respiratory bronchioles) and air
spaces. The macrophages are distinctive in that they
have abundant cytoplasm containing finely granular
dusty brown pigment. In RBILD the changes are patchy
at low magnification and limited to the airways
without significant interstitial inflammation or fibrosis
(Figure 5). The appearance is indistinguishable from
isolated respiratory bronchiolitis (RB), a common,
incidental finding in otherwise asymptomatic cigarette
smokers without clinical evidence of restrictive lung
Figure 5. Photomicrograph showing respiratory bronchiolitis in a
patient with respiratory bronchiolitis interstitial lung disease (H&E).
Pigmented (‘smoker’s’) histiocytes are present within the lumens of
distal bronchioles and immediately adjacent air spaces without
associated interstitial pneumonia.
Figure 6. Photomicrograph showing desquamative interstitial
pneumonia characterized by a combination of pigmented (‘smoker’s’)
intra-alveolar histiocytes and concomitant interstitial thickening
due to mild, acellular fibrosis without significant associated inflam-
mation (H&E). Occasional eosinophils accompany the predominantly
histiocytic air space exudate.
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disease. RBILD may include mild fibrotic thickening of
alveolar septa immediately adjacent to the visceral
pleura in some patients, a finding of no special or
prognostic significance.24
DIP includes the airway-centred changes described
in RBILD, but also shows areas in which the process is
more diffuse. There may be accompanying mild inter-
stitial thickening due to alveolar pneumocyte hyper-
plasia or mild collagen deposition (Figure 6), but
interstitial inflammation is minimal or absent. DIP
differs histologically from UIP in that the changes are
more uniform at low magnification with a focally
bronchiolocentric distribution and without significant
fibrosis, honeycomb change or fibrotic scarring.
s ignif icance of pathological diagnoses
of dip or rbild
Neither DIP nor RBILD should be viewed as free-
standing histopathological entities, since areas resem-
bling both commonly occur as incidental findings in
cigarette smokers with other lung diseases, including
UIP.19,25 There are no histological changes that
reliably separate patients with DIP ⁄ RBILD from those
with other lung diseases in whom RB and ‘DIP-like
reactions’ represent incidental findings.25 For that
reason, DIP ⁄ RBILD should be diagnosed only when
other forms of interstitial lung disease have been
vigorously excluded by carefully examining all aspects
of the microscopic slides and by correlating surgical
lung biopsy specimen diagnosis with clinical and
radiological features. Although incidental RB can be
recognized on transbronchial biopsy, this technique
cannot be used to diagnose DIP ⁄ RBILD.
Acute interstitial pneumonia
Most idiopathic interstitial pneumonias are chronic
processes characterized by an insidious or subacute
onset and a slowly progressive course. A small number
of patients present with the acute onset of breathless-
ness followed by rapidly progressive respiratory failure.
Some patients in this category may have acute
exacerbation of IPF (see Usual interstitial pneumonia
above), but most have AIP, also termed Hamman–Rich
disease. This acute variant of idiopathic interstitial
pneumonia is analogous to acute respiratory distress
syndrome, differing from classical cases only in that
it is not preceded by an identifiable catastrophic event
such as trauma or shock. It is the least common
of the idiopathic interstitial pneumonias. Little new
information has emerged since publication of the
international consensus classification, making AIP
perhaps the least controversial of the idiopathic
interstitial pneumonias.
clinical features
Patients with AIP present with rapidly evolving short-
ness of breath and non-productive cough of 1–3 weeks’
duration preceded by a flu-like illness characterized by
sore throat, cough, fever, myalgias and malaise.1,4,26
Men and women are affected equally, with a mean age
at diagnosis of 55 years, similar to that described for
UIP but with a much broader age range that includes
children. Most patients are severely hypoxaemic at
the time of diagnosis and require hospitalization and
mechanical ventilation. HRCT demonstrates a combi-
nation of ground glass attenuation and consolidation
in a bilateral and symmetrical distribution. AIP is
associated with a poor prognosis with an acute fatality
rate of about 70%.26 The natural history in survivors is
variable and includes patients who fully recover, others
who suffer multiple relapses, and a small number who
develop persistent chronic interstitial lung disease.27
Some survivors with persistent fibrotic lung disease
may represent patients with previously unrecognized
UIP who present with accelerated disease.
pathological features
Biopsy specimens from patients with AIP demonstrate
DAD, usually in the late or organizing stage.1,4,28,29
There are no histological features that reliably distin-
guish DAD in the setting of AIP from DAD of other
known causes. Before a diagnosis of AIP can be made,
therefore, all potential causes of DAD should be
excluded. Special stains, cultures and serological stud-
ies are especially helpful in excluding infectious causes,
and careful clinical history may provide clues to other
aetiologies.
Extensive fibroblast and myofibroblast proliferation
is the dominant finding in biopsy specimens of AIP
(Figure 7). Alveolar septa are thickened and distorted
by proliferating spindle cells within a pale-staining
basophilic matrix. The uniformity of the findings
contrasts sharply with the patchwork distribution of
highly variegated abnormalities in UIP. Intraluminal,
polypoid plugs of spindle cells indistinguishable from
those seen in organizing pneumonia may be present
and are sometimes a prominent feature. Fibroblast
proliferation is accompanied by marked hyperplasia of
cytologically atypical alveolar lining cells characterized
by nuclear enlargement and prominent nucleoli. Rem-
nants of hyaline membranes are present in some cases,
but are often inconspicuous (Figure 8). Multiple fibrin
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thrombi in small muscular arteries and squamous
metaplasia of bronchiolar epithelium are manifesta-
tions of acute lung injury that can be important clues
to the diagnosis.
Non-specific interstitial pneumonia
NSIP was proposed in 1994 as a form of chronic
interstitial pneumonia characterized by relatively uni-
form expansion of alveolar septa by inflammation
and ⁄ or fibrosis without the geographical and temporal
heterogeneity of UIP.30 As the term implies, the
histological findings in NSIP are not specific. Findings
indistinguishable from NSIP can occur focally in other
conditions, most importantly UIP. The findings are
also non-specific from a clinical perspective given that
identical changes can occur in surgical lung biopsy
specimens from patients with a variety of underlying
causes or associations, including hypersensitivity pneu-
monia and various systemic connective tissue dis-
eases.30–32 Recognizing idiopathic NSIP as a distinct
entity is therefore a process of exclusion that, like
DIP ⁄ RBILD and AIP, requires careful correlation with
clinical and radiological information. Given the diffi-
culty in identifying patients with idiopathic NSIP, the
authors of the consensus classification suggested that
NSIP be considered ‘a provisional diagnosis until there is
further clarity on the nature of the corresponding
clinical condition’.3 In our view, clarity has emerged
and we advocate separating NSIP from UIP as an
important form of idiopathic interstitial pneumonia
with very marked differences in treatment response and
natural history.31,32
clinical features
NSIP is the second most common idiopathic interstitial
pneumonia, accounting for as many as a third of
patients undergoing surgical lung biopsy in retrospec-
tive series.31 NSIP fails to show the gender predilection
for men seen in UIP, and in some series is more
common in women.32 NSIP also differs from UIP in
that it tends to affect younger patients, with an average
age at diagnosis of around 50 years.31,32 Shortness of
breath and dry cough are the most common com-
plaints, often developing in an insidious fashion indis-
tinguishable from that described for UIP. Pulmonary
function studies show restricted lung volumes and
abnormalities of oxygenation, although the degree of
abnormality tends to be less severe compared with
patients with UIP. HRCT shows a non-specific combi-
nation of ground glass opacities, irregular lines, and
traction bronchiectasis occasionally with subpleural
sparing. The radiological findings, although frequently
characteristic, cannot reliably distinguish between
patients with NSIP and those with early or radiolog-
ically atypical UIP or certain other interstitial lung
diseases.14,33
Multiple studies have now confirmed the survival
advantage associated with a diagnosis of NSIP com-
pared with UIP.31,32 Median survival for all NSIP cases
is >9 years, with the best prognosis occurring in
patients with minimal fibrosis (cellular variant, see
below). Most patients with cellular NSIP survive, but
about half have persistent stable disease. Patients in
whom fibrosis predominates in surgical lung biopsy
Figure 8. High-magnification photomicrograph showing hyaline
membranes (arrows) in lung biopsy from patient with acute
interstitial pneumonia (H&E).
Figure 7. Low-magnification photomicrograph showing organizing
diffuse alveolar damage in a patient with acute interstitial pneumonia
(H&E). Collapse of distal alveolar spaces and dilation of alveolar
ducts result in the appearance of dramatic but uniform interstitial
thickening. Hyaline membranes are present within collapsed spaces.
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specimens do worse than those with more cellular
lesions, although still better than UIP.30,34–38 Mortality
rates for patients with fibrotic NSIP vary widely,
ranging from 11 to 68% in various studies (mean ±
SD, 30.4 ± 18.9%).6,30,32,34–36,39 Reported 5-year sur-
vival of such patients is about 76% compared with
about 45% for UIP37,38. To some extent, variation in
mortality rates reported for patients with fibrotic NSIP
reflects differences in histological definitions and the
difficulty in separating fibrotic NSIP from UIP (see
below). Survivors typically have persistent lung
disease. Corticosteroids have not been prospectively
evaluated in a randomized fashion, but may be effective
in a subset of patients, especially those with minimal
associated fibrosis.34
pathological features
A diagnosis of NSIP in surgical lung biopsy specimens
requires the presence of a chronic interstitial pneumo-
nia without findings to prompt diagnosis of a more
specific pathological process. Unlike UIP, NSIP is in
many respects a diagnosis of exclusion. Defined in this
way, NSIP spans a spectrum of histological abnormal-
ities ranging from a predominantly cellular process (i.e.
cellular NSIP) to paucicellular lung fibrosis (i.e. fibrotic
or fibrosing NSIP). The most cellular forms are char-
acterized by an alveolar septal infiltrate of mononuclear
cells that may be patchy or diffuse (Figure 9). Whether
patchy or diffuse, the qualitative features of the
interstitial abnormalities remain constant without the
geographical and temporal heterogeneity associated
with UIP (Figure 10). The inflammatory infiltrate
consists of lymphocytes and variable numbers of
admixed plasma cells. Neutrophils, eosinophils and
histiocytes are relatively inconspicuous. Granulomas
are rare in NSIP and, if present, should raise other
considerations (see below).
The relative frequency of fibrosis in NSIP is variable.
Patients with fibrotic NSIP outnumber patients with
cellular NSIP by a ratio of nearly 4:1 in published
studies, but this may reflect selection bias, in that most
Figure 9. Photomicrograph showing cellular variant of non-specific
interstitial pneumonia ⁄ fibrosis (H&E). There is a diffuse infiltrate of
predominantly lymphocytes expanding peribronchiolar interstitium
and alveolar septa in a uniform fashion. No significant fibrosis or
architectural distortion are present.
Figure 10. Low-magnification photomicrograph showing another
example of cellular non-specific interstitial pneumonia ⁄ fibrosis,
this time accompanied by mild fibrosis but without architectural
distortion (H&E).
Figure 11. Low-magnification photomicrograph showing a fibrotic
variant of non-specific interstitial pneumonia ⁄ fibrosis (H&E).
Uniform collagen deposition expands all compartments of the
interstitium, including interlobular septa, but without architectural
distortion in the form of fibrotic scars or honeycomb change. Contrast
with the patchwork distribution of qualitatively heterogeneous
abnormalities in usual interstitial pneumonia illustrated in Figure 1.
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reports are from tertiary referral centres where patients
with fibrotic interstitial lung disease may be over-
represented. In addition, there are no clearly articu-
lated criteria for separating cellular from fibrotic NSIP.
We limit the term fibrotic NSIP to those cases in which
paucicellular fibrosis with minimal or mild inflamma-
tion is the predominant feature. Defined in this way,
the extent of interstitial fibrosis is variable. Fibrosis
takes the form of uniform collagen accumulation
resulting in expansion of alveolar septa and peribron-
chiolar interstitium (Figure 11) without the patchwork
distribution characteristic of UIP. Interlobular septa
and visceral pleura may also be involved. Pathology
reports should comment on the presence and extent
of interstitial fibrosis, since it is associated with sig-
nificantly increased risk for disease-specific mortal-
ity.1,4,30–32 Associated smooth muscle hyperplasia
tends to be less extensive than that seen in UIP.
Fibroblast foci should be absent or, at most, rare and
inconspicuous. Honeycomb change and broad zones of
scarring should be absent, an important feature in
distinguishing fibrotic NSIP from UIP. Patchy intra-
luminal fibrosis resembling organizing pneumonia is
common, but should be a focal and relatively incon-
spicuous finding that is overshadowed by the intersti-
tial changes.
Controversies in classification and diagnosis
of idiopathic interstitial pneumonias
‘pattern’ versus ‘diagnosis ’ and the role
of surgical lung biopsy
The authors of the consensus classification advocated
use of the term ‘pattern’ when reporting lung biopsy
findings in order to distinguish the pathological diag-
nosis from a final ‘clinico-radiological-pathological
diagnosis’. Although this may emphasize the value of
an iterative dynamic process that correlates histolog-
ical findings with other relevant data, it seems to us
unnecessary and potentially dangerous—unnecessary
in that the same could be said of nearly all conditions in
which pathological diagnoses play a key role in disease
recognition. Many pathological diagnoses are not
isolated events but, rather, essential components of
an iterative process in which final interpretation is
dynamic and framed by ongoing data collection. For
example, a lung biopsy diagnosis of adenocarcinoma
may be reinterpreted as metastatic adenocarcinoma
after discovery of a previously occult primary malig-
nancy outside the lung. This possibility should not
drive an argument for substituting the term ‘adeno-
carcinoma pattern’, terminology that may interfere
with the end-user’s recognition that the diagnosis of
malignancy is certain. Indeed, the danger in using the
term ‘pattern’ is that others may not fully understand
those circumstances in which the specificity of the
histopathological findings is the primary driver of a
final diagnosis.
UIP stands alone among the idiopathic interstitial
pneumonias in being a specific histopathological entity.
Several studies have demonstrated the primary role of a
lung biopsy specimen diagnosis of UIP in establishing a
clinical diagnosis of IPF.14,15,18,40,41 This is especially
important given that many patients are selected for
lung biopsy because there is some level of doubt
regarding the likelihood of IPF. It is precisely in this
context that a biopsy diagnosis of UIP establishes the
clinical diagnosis with certainty, and in this context the
biopsy result remains the single most powerful predic-
tor of disease-specific mortality at the time of diagno-
sis.6,14 Other histological forms of idiopathic interstitial
pneumonia are less specific, and perhaps for these a
stronger argument can be made for using the term
‘pattern’. In our view, however, this diminishes the
role of the pathologist to that of technician rather than
a diagnostician engaged in proactively integrating
histological observations with clinical information.
This proactive approach is common in other areas
of medicine, for example orthopaedic oncology and
hepatology, in which the pathologist and the patho-
logy report are the driving force for integrating
relevant clinical, laboratory and radiological infor-
mation that facilitates accurate interpretation of
microscopic findings.
The second argument for using the term ‘pattern’ in
reporting diagnoses of UIP is that it occurs in patients
for whom the term IPF is deemed inappropriate. The
implication is that sorting patients with UIP into
different clinical groups may impact therapeutic
options and outcome. The preponderance of evidence
suggests that patients with a biopsy specimen diagnosis
of UIP have a form of fibrotic lung disease that is
relatively insensitive to conventional immunosuppres-
sive therapy and likely to be associated with a
progressive course regardless of the underlying or
associated condition. Although a number of studies
have indicated a better prognosis for UIP associated
with collagen vascular diseases, others have found no
difference in survival when comparing patients with
and without connective tissue disease.9,42–44 The
differences observed in some studies may be related to
confounding factors such as younger age, greater
prevalence of women, and lower smoking rates in
patients with collagen vascular disease, factors that
themselves are associated with a better prognosis.44
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Furthermore, the survival advantage does not apply to
patients with rheumatoid arthritis.44 Similarly, asbes-
tos can be viewed as a potential cause of UIP without
any meaningful differences between asbestosis and IPF
in terms of signs and symptoms, morphology, treat-
ment response or natural history.45,46 Even in patients
with an exposure history suggesting chronic hyper-
sensitivity pneumonias as an alternative, a biopsy
specimen diagnosis of UIP predicts a natural history
indistinguishable from IPF.47 Returning to our previ-
ous analogy, adenocarcinoma of the lung occurs in
smokers and non-smokers, and whereas smoking
history may predict important differences in the
molecular underpinnings of carcinogenesis, the clinical
implications of a pathological diagnosis of adenocarcin-
oma remain the same.
distinguishing rbild from dip
RBILD and DIP may be separable at their extremes,
but demonstrate a degree of histological overlap that
blurs distinction in a substantial proportion of cases.
The consensus classification recognized this overlap in
stating that DIP ‘is considered by many to represent
the end of a spectrum of RB-ILD in view of its similar
pathology and almost invariable association with
cigarette smoke’.3 In theory, RBILD comprises a
lesion limited to the airways, whereas DIP is a more
diffuse process. From its inception, however, DIP
included patients with patchy airway-centred lesions
described as mild or early disease.2 This overlap was
observed in four of 10 patients with respiratory
bronchiolitis reported by Moon and associates,
prompting the authors to conclude that ‘the distinc-
tion between RBILD and DIP is histopathologically
quite arbitrary, being dependent on the field of
focus’.48 For these reasons, we combine DIP and
RBILD into a single category, separating them when
possible and arbitrarily choosing between the two on
occasion.
distinguishing dip from nsip
The consensus classification highlighted the relation-
ship between DIP and the fibrotic variant of NSIP as an
area of uncertainty.3 A recent study has suggested that
when the term DIP is reserved for biopsy specimens
showing well-established diffuse interstitial pneumonia
accompanied by fibrosis, it shows a weaker relationship
to cigarette smoking and may have more in common
with NSIP than with RBILD.23 In our view, the term
DIP remains appropriate for lung biopsy specimens
showing a combination of pigmented alveolar macro-
phages typical of RBILD as well as areas in which lung
parenchyma is more diffusely involved but without
significant fibrosis. In those cases characterized by a
combination of pigmented alveolar macrophages and a
true interstitial pneumonia accompanied by fibrosis,
we prefer the term NSIP. We acknowledge, however,
that in some patients distinguishing between DIP and
NSIP may be arbitrary. Fortunately, the distinction is
unlikely to impact either patient management or
prognosis.
distinguishing fibrotic nsip from uip
Separating fibrotic NSIP from UIP is perhaps the
greatest challenge when it comes to making meaning-
ful distinctions between the idiopathic interstitial
pneumonias.49 Separating fibrotic NSIP from UIP
hinges on recognition of the patchwork distribution,
fibroblast foci and honeycomb change typical of UIP.19
In our view, recognition of any one of these features
in a specimen for which a diagnosis of fibrotic NSIP
is being contemplated is reason for caution. In this
circumstance, correlation with other clinical data,
especially the findings on HRCT, may be helpful.
The primary problem is that areas typical of NSIP
can occur focally in other conditions, making sampling
bias a potential barrier to accurate diagnosis. In a
review of 20 explanted lungs with UIP, all but three
showed isolated areas that were indistinguishable from
NSIP (‘NSIP-like areas’).19 Other studies have shown
that the presence of UIP in even a single piece of tissue
defined a survival curve typical of IPF in patients from
whom surgical lung biopsy specimens taken from more
than one site demonstrated both UIP and NSIP
(‘discordant UIP’).50,51 For these reasons, establishing
a diagnosis of idiopathic NSIP requires the absence of
clinical, radiological or pathological findings to suggest
an alternative. For example, a biopsy diagnosis of
fibrotic NSIP in a patient with bibasilar honeycomb
change on HRCT is almost certainly a sampling error in
a patient with UIP. Although the consensus classifica-
tion would suggest that this issue be resolved by
producing a pathology report with a diagnosis of
fibrotic NSIP pattern, it is our practice instead to offer a
descriptive diagnosis (e.g. chronic interstitial pneumo-
nia with fibrosis most consistent with UIP) and a
comment acknowledging that the biopsy falls short of
being diagnostic but the imaging studies indicate UIP
as the correct diagnosis. This approach avoids the risk
of others engaged in a patient’s care having to
reconcile seemingly discordant information when com-
paring pathology reports with other clinical or radio-
logical data.
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recognition of unclassif iable les ions
in patients suspected of having idiopathic
interstit ial pneumonias
Occasionally, lung biopsy specimens show a fibrotic
lesion in a clinical context strongly suggesting an
idiopathic interstitial pneumonia but without suffi-
ciently distinctive radiological or histological findings
to allow confident diagnosis of a specific entity.
Typically, these specimens show fibrosis, but with
neither the combination of a patchwork distribution,
fibroblast foci and honeycomb change diagnostic of UIP
nor the uniform parenchymal involvement required for
a diagnosis of NSIP. In other cases a portion of the
specimen may show a lesion unusually cellular for UIP
but with other areas in which the degree of honeycomb
change precludes a diagnosis of NSIP. The consensus
classification anticipated this category and proposed
the term unclassifiable interstitial pneumonia for those
patients in whom no clear diagnosis could be made. No
additional information has emerged regarding either
the frequency or significance of this group.
role of expert interpretation of lung biopsy
spec imens
The importance of subspecialty expertise in accurately
and consistently recognizing the various forms of
idiopathic interstitial pneumonia is controversial. The
consensus classification suggested that the ‘interobserver
variability of pathological interpretation, particularly
among general pathologists, needs to be defined’.3 Since
then, Nicholson and colleagues have examined the
performance of 10 pathologists experienced in biopsy
diagnosis of diffuse lung disease by circulating slides
identified only with patient age, sex and biopsy site.52
No additional clinical information was provided. With
this limited information there were reasonably high
rates of interobserver agreement when diagnoses of
UIP, DIP and DAD (j coefficients 0.58, 0.58 and 0.69,
respectively) were made with confidence. There were
low rates of agreement for NSIP (j coefficient 0.31).
This is not surprising given the importance of additional
clinical and radiological data when interpreting slides
for which NSIP is a consideration.
Flaherty and associates compared the diagnostic
performance of community and academic physicians
also using rates of interobserver agreement, rather than
patient outcome, as a primary end-point.40 Although
this study is frequently cited as evidence that academic
pathologists perform better, the academic participants
comprised a group that has worked together extensively
in this area, including publications in which they had
previously analysed their rates of interobserver agree-
ment. In addition, those patients in whom biopsy results
were associated with the lowest rates of interobserver
agreement between community and academic pathol-
ogists tended to be complex, with significant disagree-
ment among all participants. For example, a patient
ultimately assigned a diagnosis of ‘CVD related IIP’
(patient 376) was thought to have UIP by three of four
academic pathologists and two of two community
pathologists prior to knowledge of the clinical circum-
stances. Interestingly, half of both the academic and
community radiologists and even one academic clini-
cian assigned this patient a final diagnosis of UIP. After
clinical information was shared with the pathologists,
one academic and both community practitioners
remained committed to a diagnosis of UIP, an interpre-
tation that probably reflects disagreement regarding
terminology rather than a substantive diagnostic error.
Lettieri et al. also showed low rates of interobserver
agreement between community-based pathologists and
pathologists with subspecialty expertise in pulmonary
diseases (j 0.21; P < 0.0001) in a cohort of surgical
lung biopsy specimens from patients referred to a
tertiary care centre.53 In this study the authors argued
that expert opinion resulted in a change in manage-
ment in 60% of patients, but left open the question of
whether changes in management impacted patient
outcome. In addition, there was no comparison of
patient outcomes between those whose biopsy speci-
mens were not reviewed by a subspecialist and those
whose specimens were referred for expert review.
On the basis of the available data as well as our own
anecdotal experience, no broad statement can be made
regarding which patients’ interests are best served by
having their surgical lung biopsy specimens reviewed
by recognized experts. It is our view that there are
competent practitioners in both community and aca-
demic practices with variable degrees of interest and
experience. Many patients with straightforward diag-
noses, such as classical UIP, are well served by
interested and experienced community practitioners,
and there is little rationale for routine re-review in the
absence of potentially discordant clinical or radiological
findings.
role of transbronchial biopsies
The role of transbronchial biopsies in managing
patients suspected of having idiopathic interstitial
pneumonia remains controversial. The previously ref-
erenced consensus statement on idiopathic pulmo-
nary fibrosis asserts that ‘transbronchial biopsies are
not helpful in making the diagnosis of UIP’.8 The
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subsequent consensus classification also describes
transbronchial biopsies as ‘not useful’ in the diagnosis
of idiopathic interstitial pneumonias, citing acute
interstitial pneumonia as the exception.3 This view-
point is usually supported by referencing a paper
published in 1981, a paper that antedates current
diagnostic criteria and the advent of modern broncho-
scopes, biopsy instruments and imaging techniques.54
More recent studies have suggested that transbronchial
biopsies may be more useful in managing immuno-
competent patients with idiopathic interstitial pneumo-
nias, especially UIP.55,56 In a retrospective case study
limited to patients with UIP, about a third of trans-
bronchial biopsy specimens showed some combination
of fibrosis distributed in a patchwork pattern, fibroblast
foci, and honeycomb change considered diagnostic or
at least suggestive of UIP (Figure 12). In an accompa-
nying editorial, Churg and Schwarz recommended that
transbronchial biopsies not be used to diagnose UIP
until these preliminary observations were validated in a
prospective and blinded fashion.57 Although we agree
that additional studies are necessary to understand
more fully the diagnostic sensitivity and specificity of
transbronchial lung biopsy in this setting, in our
combined experience there is a small subset of patients
in whom UIP can be diagnosed with confidence if
carefully correlated with clinical and radiological
findings.
Summary
Lung biopsy specimen diagnosis is a powerful and
essential tool for accurately diagnosing patients with
idiopathic interstitial pneumonia. Differentiating these
entities is important because of significant differences
in therapeutic options and prognosis. As HRCT gains
widespread acceptance as a primary diagnostic
modality for some of these entities, biopsies will be
used mainly in patients with atypical and non-
diagnostic HRCT results. The pathological diagnosis
will be more important than ever in managing these
patients.
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